Reaction
Philadelphia Positive Chronic Myeloid Leukaemia reporting signals
As of the last recalculation, Philadelphia Positive Chronic Myeloid Leukaemia appears in 92 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is DASATINIB (PRR 232.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dasatinib | 27 | 232.2 | 232.4 |
| Imatinib | 15 | 229.7 | 229.9 |
| Ursosiol | 15 | 208.4 | 208.5 |
| Ursodiol | 15 | 186.0 | 186.1 |
| Sirolimus | 9 | 167.4 | 167.5 |
| Nilotinib | 15 | 137.3 | 137.4 |